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PRELIMINARY AND SHORT REPORTS
RONIACOL TARTRATE IN THE TREATMENT OF
DERMATITIS HERPETIFORMIS*
0. 5. PHILPOTT, M.D., A. R. WOODBURNE, M.D., AND J. A. PHILPOTT, JR., M.D.
For many decades, arsenic had been the standard if relatively ineffective method o1
treatment of dermatitis herpetiformis. In 1940Costello (1) presented his results with sulfa-
pyridine which has, in general, proved to be a much more effective method of treatment.
Johnson and Binkley in 1950 (2) found that niacin in doses of 50 to 100 mgms. q.i.d. was
effective in many cases and offered this drug as almost as effective as sulfapyridine and
without many of its unpleasant side effects. In their paper, the authors raised the question
as to whether the beneficial effect of the sulfapyridine was due to its "sulfa" effect or to
the pyridine radical which was present. It would seem that since niacin had a very bene-
ficial effect in this disease, and since it contained no "sulfa", the beneficial effect must be
due to the pyridine radical.
Later in 1950 roniacol, an ethylated derivative of niacin, was developed as a potent
peripheral vasodilator. We thought it worth while to try it in dermatitis herpetiformis to
see if it was as effective as sulfapyridine and niacin.
We have used roniacol tartrate in six cases of dermatitis herpetiformis with very satis-
factory results. Untoward reactions have been mild. The patient must be warned of the flush
that not uncommonly follows its ingestion. Beyond this we have had occasional difficulty
with nausea, giddiness and fainting spells; however, we have had adults and children on
this drug for from three months to a year and in general they have all tolerated it well.
CAsE 1
H. G., male, age 35 had been followed by us for eight years. We were able to keep him
comfortable and reasonably free of lesions on a dose of sulfapyridine ranging from G 0.5
t.i.d. to q.i.d. Over all these years, however, he was on the verge of leukopenia at all times
with white blood cell counts ranging from 2,800 to 6,000. We were constantly worried about
this situation, but his eruption was severe and without the drug he was entirely miserable
and unable to work. We tried niacin alone for awhile with indifferent results. Niacin 50 mgm.
q.i.d. with sulfapyridine G 0.5 b.i.d. gave better control but he still showed a moderate
leukopenia.
In October 1950 the patient developed a nephritis at which time he was hospitalized and
we were able to have him under complete control in consultation with an able internist. We
discontinued all drugs for awhile and he promptly showed a violent general flare of the
eruption and became extremely uncomfortable. After two weeks without medication the
nephritis improved and the internist agreed to a trial with roniacol tartrate. This was
started with 50 mgm. q.i.d. with moderate improvement; after one week and no worsening
of his kidney condition we raised the dose to 100 mgm. q.i.d. On this dose the patient would
experience a flush of the entire skin if the drug was taken on an empty stomach but other-
wise showed no untoward reactions.
He has been kept on roniacol tartrate now for nine months and is as comfortable as with
the sulfapyridine and he no longer shows the tendency to leukopenia.
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CASES 2 AND 3
B. J., female, age 3 and S. A., female, age l will be described together since they were
almost identical juvenile cases. Both presented some difficulty in diagnosis at first but
showed a strong flare when iodide was administered. Following this they were put on sulfa-
pyridine for short periods with immediate clearing of their eruption. After two weeks they
were switched to roniacol tartrate 25 mgm. q.i.d. with entire comfort, only rare lesions and
no untoward symptoms other than an occasional flush reaction.
CASES 4, 5 AND 6
These cases were typical adult cases whom we had followed for a few months on sulfa-
pyridine and then changed to roniacol tartrate with equally good results.
CONCLUSIONS
We here offer a new drug, roniacol tartrate, as an adjunct to the treatment of dermatitis
herpetiformis. While in some cases it may not be quite so effective as sulfapyridine it is
recommended by its very mild toxic reactions and by the fact that it apparently does not
depress the hematopoietic system.
We are inclined to agree with Johnson and Binkley (2) that probably the beneficial effect
of sulfapyridine is not due to the "sulfa" content but due to the pyridine radical since here
is another drug with the pyridine radical and without the sulfa radical which is effective
in dermatitis herpetiformis.
REFERENCES
1. COSTELLO, M. J.: Dermatitis herpetiformis treated with sulfapyridine. Arch. Dermat. &
Syph., 41: 134, Jan. 1940.
2. JoHNsoN, K. H., Ja. AND BINKLEY, G. W.: Nicotinic acid therapy of dermatitis herpeti-
formis. J. Invest. Dermat., 14: No. 4, April 1950.
